Evidence map›Paper›PMID 29734646›Full record

ArticleSensors (Basel, Switzerland)2018

Evaluation of Meropenem Pharmacokinetics in an Experimental Acute Respiratory Distress Syndrome (ARDS) Model during Extracorporeal Membrane Oxygenation (ECMO) by Using a PenP

Max Andresen, Joaquin Araos, Kwok-Yin Wong, Yun-Chung Leung, Lok-Yan So, Wai-Ting Wong, Salvador Cabrera, Camila Silva, Leyla Alegria, Alejandro Bruhn and 1 more

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Max AndresenLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. andresen@med.puc.cl.
Joaquin AraosLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. juaccco@gmail.com.
Kwok-Yin WongState Key Laboratory of Chirosciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China. kwok-yin.wong@polyu.edu.hk.
Yun-Chung LeungState Key Laboratory of Chirosciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China. thomas.yun-chung.leung@polyu.edu.hk.
Lok-Yan SoState Key Laboratory of Chirosciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China. lok-yan.so@polyu.edu.hk.ORCID 0000-0002-7370-0986
Wai-Ting WongState Key Laboratory of Chirosciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China. wai-ting.wong@polyu.edu.hk.
Salvador CabreraDepartamento de Farmacia, Facultad de Farmacia, Universidad de Concepción, Víctor Lamas 1290, Concepción 4070386, Chile. scabrera@ssconcepcion.cl.
Camila SilvaLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. cfsilvag2@gmail.com.
Leyla AlegriaLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. lalegria@med.puc.cl.
Alejandro BruhnLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. alejandrobruhn@gmail.com.ORCID 0000-0001-8034-1937
Dagoberto SotoLaboratory 103B, Centro de Investigaciones Médicas, Departamento de Medicina Intensiva, Facultad de Medicina y Hospital Clínico, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. dasotom@uc.cl.
Pontificia Universidad Católica de Chile · CLHong Kong Polytechnic University · HKUniversity of Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of antibiotics is mandatory in patients during extracorporeal membrane oxygenation (ECMO) support. Clinical studies have shown high variability in the antibiotic concentrations, as well as sequestration of them by the ECMO circuit, suggesting that the doses and/or interval administration used during ECMO may not be adequate. Thus, a fast response sensor to estimate antibiotic concentrations in this setting would contribute to improve dose adjustments. The biosensor PenP has been shown to have a dynamic range, sensitivity and specificity useful for pharmacokinetic (PK) tests in healthy subjects. However, the use of this biosensor in the context of a complex critical condition, such as ECMO during acute respiratory distress syndrome (ARDS), has not been tested.

objectivesTo describe, by using PenP Biosensor, the pharmacokinetic of meropenem in a 24-h animal ARDS/ECMO model.

methodsThe PK of meropenem was evaluated in a swine model before and during ECMO.

resultsThe PK parameters such as maximum concentration (Cmax), elimination rate constant (Ke), and cleareance (Cl), were not significantly altered during ECMO support.

conclusions(a) ECMO does not affect the PK of meropenem, at least during the first 24 h; and (b) PenP has the potential to become an effective tool for making medical decisions associated with the dose model of antibiotics in a critical patient context.

Indexed as

Biosensing TechniquesAnimalsAnti-Bacterial AgentsArea Under Curvebeta-LactamasesDisease Models, AnimalExtracorporeal Membrane OxygenationHalf-LifeMeropenemRespiratory Distress SyndromeROC CurveSwineThienamycinsAnti-Bacterial Agentsbeta-LactamasesMeropenemThienamycinsbiosensorECMOmeropenemPenPpharmacokinetic

Identifiers

PMID29734646
PMCPMC5982397
OpenAlexW2799754189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.